SLI Medical Acceptable Dating: we will ship >= 90 days
Strength
5 mg / 100 mL
Type
Intravenous
UNSPSC Code
51182415
Volume
100 mL
Features
Ready-to-use formulation
Zoledronic acid injection is a bisphosphonate indicated for the treatment of: Hypercalcemia of malignancy
multiple myeloma and bone metastases from solid tumors
The zoledronic acid injection infusion time must not be less than 15 minutes given over a constant infusion rate
Zoledronic acid injection must not be mixed with calcium or other divalent cation-containing infusion solutions
such as Lactated Ringer’s solution
and should be administered as a single intravenous solution in a line separate from all other drugs
Infusion bottle with built-in plastic hanger
One bottle with 100 mL solution contains 5.330 mg of zoledronic acid monohydrate
equivalent to 5 mg zoledronic acid on an anhydrous basis
Inactive Ingredients: 4950 mg of mannitol
